๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease: A reappraisal

โœ Scribed by Colin Baigent; Carlo Patrono


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
133 KB
Volume
48
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


The cost-effectiveness of aspirin versus
โœ Chin Hur; Lee S. Simon; G. Scott Gazelle ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 122 KB

## BACKGROUND. Aspirin therapy is accepted widely for secondary prevention in patients with documented cardiovascular disease, but there is a growing trend among healthy individuals to use aspirin as primary chemoprevention for both cardiovascular and oncologic diseases. Accruing evidence suggests